Table 2.

Ovarian stimulation response among all subjects in general and stratified

	Correctly Stimulated	Over-Stimulated	Failed to Stimulate
Overall 157 subjects	49%	45.4%	5.6%
Serum AMH Stratified (N = 84)
AMH ≥ 1.5 ng/ml
FD dose 2- 3 mcg (N = 29)	79%	17.6%	3.4%
FD doses > 3 -12mcg (N = 29)	20%	62%	18%
AMH < 1 ng/ml
FD dose ≤ 4 mcg (N = 5)	75%	25%	0%
FD doses 6–12 mcg (N = 31)	29%	48%	23%
FD dose 4- < 6 mcg (N = 0)	NA	NA	NA
AMH ≥ 1 and < 1.5 ng /ml
FD dose 3–12 mcg (N = 19)	53%	47%	0%
FD dose 3-6mcg (N = 9)	67%	33%	0%
FD dose 3–4 mcg (N = 6)	80%	20%	0%
FD dose 7–12 mcg (N = 10)	40%	60%	0%
FD dose 6–7 mcg (N = 0)	NA	NA	NA
AFC Stratified (N = 134)
AFC ≥ 10
FD dose 2–12 mcg (N = 78)	52%	40%	8%
FD dose > 3 mcg (N = 37)	29%	60%	11%
FD dose 2- 3 mcg (N = 41)	73%	24.6%	2.4%
AFC < 6
FD dose 3–12 mcg (N = 36)	44%	50%	6%
FD dose 3- 4 mcg (N = 6)	50%	50%	0%
FD dose > 4–12 (N = 30)	44%	47%	9%
FD dose 3 mcg (N = 3)	100%	0%	0%
AFC 6–9
FD dose 3–12 mcg (N = 12)	25%	75%	0%
FD dose 6–12 mcg (N = 17)	12%	88%	0%
FD dose 3mcg (N = 3)	100%	0%	0%
Body Weight Stratified (N = 71)
Weight ≥ 80 kg
FD dose 3–12 mcg (N = 26)	50%	27%	23%
FD dose 4–6 mcg (N = 20)	50%	25%	25%
FD dose > 6 mcg (N = 6)	50%	33%	17%
Weight < 80 kg
FD dose 2–12 mcg (N = 45)	47%	53%	0%
FD dose 2–4 mcg (N = 17)	71%	29%	0%
FD dose 5.33–12 mcg (N = 28)	29%	71%	0%
FD dose 4–5.33 (N = 0)	NA	NA	NA